5 Matching Annotations
  1. Apr 2026
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    p16 expression confers sensitivity to CDK2 inhibitors in cyclin E1–driven ovarian cancers
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13089646/
  3. Dec 2025
  4. www.nature.com www.nature.com
    CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41523-025-00851-7
  5. Mar 2025
  6. www.sciencedirect.com www.sciencedirect.com
    CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610825000583
  7. Mar 2024
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10905675/
  9. Feb 2024
  10. 52.53.155.43 52.53.155.43
    cd-23-0954-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/aaf525c30ae01b53e260240fad732783dfb4bbac/cd-23-0954-html.html